Adaptin Bio APTN
OTC APTN
$6.27 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Adaptin Bio (APTN) Net Equity Issued and Repurchased (2025 - 2026)

Updated

Adaptin Bio (APTN) posted Net Equity Issued and Repurchased of $260,000 for Q2 2026, down 60.1% from the prior quarter.

Analysis

Adaptin Bio (APTN) Net Equity Issued and Repurchased (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at Adaptin Bio was $1.91 million; for FY2025, it was $7.16 million.

  • Annual Net Equity Issued and Repurchased shows a three-year compound annual growth rate of 2328.5% (FY2022 to FY2025).
  • In prior years, Adaptin Bio's Net Equity Issued and Repurchased was $500.00 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Adaptin Bio 56.76 Mn 54.75 Mn - 260,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 260,000.00
Mar 31, 2026 652,000.00
Dec 31, 2025 999,999.00
Mar 31, 2025 6.16 Mn
API Access

Adaptin Bio Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=APTN&period=max&api_key=YOUR_API_KEY